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Résumé en
anglais
OBJECTIVE: Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is
caused by mutations in the SACS gene. SACS encodes sacsin, a protein whose
function remains unknown, despite the description of numerous protein domains
and the recent focus on its potential role in the regulation of mitochondrial
physiology. This study aimed to identify new mutations in a large population of
ataxic patients and to functionally analyze their cellular effects in the mitochondrial
compartment.
METHODS: A total of 321 index patients with spastic ataxia selected from the
SPATAX network were analyzed by direct sequencing of the SACS gene, and 156
patients from the ATAXIC project presenting with congenital ataxia were
investigated either by targeted or whole exome sequencing. For functional analyses,
primary cultures of fibroblasts were obtained from 11 patients carrying either mono-
or biallelic variants, including 1 case harboring a large deletion encompassing the
entire SACS gene.
RESULTS: We identified biallelic SACS variants in 33 patients from SPATAX, and in
5 nonprogressive ataxia patients from ATAXIC. Moreover, a drastic and recurrent
alteration of the mitochondrial network was observed in 10 of the 11 patients tested.
INTERPRETATION: Our results permit extension of the clinical and mutational
spectrum of ARSACS patients. Moreover, we suggest that the observed
mitochondrial network anomalies could be used as a trait biomarker for the
diagnosis of ARSACS when SACS molecular results are difficult to interpret (ie,
missense variants and heterozygous truncating variant). Based on our findings, we
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